Auke Beishuizen

Utrecht, UT 3584CS, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

External Validation and Feedback-Driven Improvement of the Diagnostic Model for Pediatric Cervical Lymphadenopathy.

External Validation and Feedback-Driven Improvement of the Diagnostic Model for Pediatric Cervical Lymphadenopathy.

Journal: Cancers

Published: June 11, 2026

EuroNet-PHL-LP1: Complete resection or low-dose chemo for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.

EuroNet-PHL-LP1: Complete resection or low-dose chemo for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.

Journal: Blood advances

Published: January 16, 2026

EuroNet-PHL-LP1: complete resection or low-dose chemotherapy for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.

EuroNet-PHL-LP1: complete resection or low-dose chemotherapy for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.

Journal: Blood advances

Published: January 16, 2026

Early Detection of Acute and Early-Onset Cancer Therapy-Related Cardiac Dysfunction in Children With Cancer Using a Multiparametric Approach: Methodological Aspects of the EARLY Study.

Early Detection of Acute and Early-Onset Cancer Therapy-Related Cardiac Dysfunction in Children With Cancer Using a Multiparametric Approach: Methodological Aspects of the EARLY Study.

Journal: Cancer medicine

Published: July 25, 2025

Quantitative Deauville Scoring to Uncover Prognostic Information from 18F-FDG PET-Based Response Assessment: Data from the EuroNet-PHL-C1 Trial.

Quantitative Deauville Scoring to Uncover Prognostic Information from 18F-FDG PET-Based Response Assessment: Data from the EuroNet-PHL-C1 Trial.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: January 28, 2025

Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical Trial.

Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical Trial.

Journal: JAMA oncology

Published: January 02, 2025

Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults: A Nonrandomized Clinical Trial.

Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults: A Nonrandomized Clinical Trial.

Journal: JAMA oncology

Published: January 02, 2025

Prevalence, pattern and prognosis of lung lesions in pediatric Hodgkin lymphoma.

Prevalence, pattern and prognosis of lung lesions in pediatric Hodgkin lymphoma.

Journal: Scientific reports

Published: December 03, 2024

Fertility-Preserving Treatments and Patient- and Parental Satisfaction on Fertility Counseling in a Cohort of Newly Diagnosed Boys and Girls with Childhood Hodgkin Lymphoma.

Fertility-Preserving Treatments and Patient- and Parental Satisfaction on Fertility Counseling in a Cohort of Newly Diagnosed Boys and Girls with Childhood Hodgkin Lymphoma.

Journal: Cancers

Published: April 25, 2024

NOTCH1 fusions in pediatric T-cell lymphoblastic lymphoma: A high-risk subgroup with CCL17 (TARC) levels as diagnostic biomarker.

NOTCH1 fusions in pediatric T-cell lymphoblastic lymphoma: A high-risk subgroup with CCL17 (TARC) levels as diagnostic biomarker.

Journal: HemaSphere

Published: April 08, 2024

Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.

Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.

Journal: Blood

Published: January 12, 2024

Single-cell RNA sequencing of pediatric Hodgkin lymphoma to study the inhibition of T cell subtypes.

Single-cell RNA sequencing of pediatric Hodgkin lymphoma to study the inhibition of T cell subtypes.

Journal: HemaSphere

Published: December 22, 2023

Showing 1-12 of 68

Last Updated: 09/26/2026